The Importance of Early Treatment in Middle Ear Disease

por Steele, N. C.
Publicado 1890

Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo

por Steele, N, Finn, P, Brown, R, Plumb, J A
Publicado 2009

The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years

por Gilsenan, A., Harding, A., Kellier-Steele, N., Harris, D., Midkiff, K., Andrews, E.
Publicado 2018

A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer

por Steele, N, Anthony, A, Saunders, M, Esmarck, B, Ehrnrooth, E, Kristjansen, P E G, Nihlén, A, Hansen, L T, Cassidy, J
Publicado 2012

Long-term cancer surveillance: results from the Forteo Patient Registry Surveillance Study

por Gilsenan, A., Harris, D., Reynolds, M., McSorley, D., Midkiff, K., Jackson, L., Muldavin, B., Kellier-Steele, N., Andrews, E.
Publicado 2020

Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer

por Basu, B, Krebs, M G, Sundar, R, Wilson, R H, Spicer, J, Jones, R, Brada, M, Talbot, D C, Steele, N, Ingles Garces, A H, Brugger, W, Harrington, E A, Evans, J, Hall, E, Tovey, H, de Oliveira, F M, Carreira, S, Swales, K, Ruddle, R, Raynaud, F I, Purchase, B, Dawes, J C, Parmar, M, Turner, A J, Tunariu, N, Banerjee, S, de Bono, J S, Banerji, U
Publicado 2018